The effects of body fat distribution on pulmonary function and respiratory muscle strength in obese individuals Obez Bireylerde Vücut Yaǧ Daǧiliminin Pulmoner Fonksiyon ve Solunum Kaslari Kuvveti Üzerine Etkileri
Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi, cilt.52, sa.1, ss.15-18, 2006 (Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 52 Sayı: 1
- Basım Tarihi: 2006
- Dergi Adı: Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi
- Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.15-18
- Anahtar Kelimeler: Obesity, Pulmonary function tests, Respiratory muscles
- Ankara Yıldırım Beyazıt Üniversitesi Adresli: Hayır
Özet
Objective: The aim of this study was to determine the effects of body fat distribution on pulmonary function test (PFT) and respiratory muscle strength of obese individuals who did not have evidence of obstructive airway or parenchymal disease or other underlying disease affecting their respiratory system. Materials and methods: Seventy-six obese and 43 non-obese subjects who admitted to Ankara Physical Medicine and Rehabilitation Education and Research Hospital outpatient clinic were recruited to our study. Body mass index, waist-to-hip ratio, skinfolds thickness, pulmonary function test (PFT) and maximal inspiratory and expiratory pressures (MIP, MEP) were measured in both groups. Grip strength was evaluated by Colin dynamometer. Results: FEF25-75% value was lower in obese subjects than control group (p=0.026). No significant differences in other PFT parameters including FVC, FEV1, FEV1/FVC, FEF50%, PEF, VC were observed between the two groups. Furthermore, the restrictive ventilatory defect was found in 14.47% of obese subjects. Triceps skinfold thickness had significant negative correlation with PFT, MIP and MEP parameters. In addition, biceps skin fold thickness had significant negative correlation FVC, FEV1 and MIP values. Conclusion: In this study, the distribution of body fat was found to affect PFT in obese subjects. Standard PFT parameters allow recognition of pulmonary dysfunction, the marker of which is a low maximal ventilatory volume in obese individuals.